GlassScriptPhysician profile
David Wayne Drevna
NPI 1700270840
$15,460.06
in general payments reported to CMS, 2019-2025
48 companies · $5,759 in 2025
The $5,759 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.63 · 2020: $3,137 · 2021: $1,141 · 2022: $1,518 · 2023: $2,283 · 2024: $1,589 · 2025: $5,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,515 · Travel and Lodging: $2,482 · Consulting Fee: $1,388 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,515.44 |
| Travel and Lodging | $2,481.54 |
| Consulting Fee | $1,387.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Education | $246.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $2,069.09 | 2020-2025 | Provenge |
| Boston Scientific Corporation | $1,975.13 | 2019-2025 | Ams 700 |
| Procept Biorobotics Corporation | $1,918.69 | 2021-2025 | Aquabeam System |
| Janssen Biotech, INC. | $1,800.93 | 2021-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $1,234.29 | 2020-2025 | Xtandi, Myrbetriq |
| Teleflex LLC | $1,193.94 | 2021-2025 | Urolift, Barrigel |
| Avyxa Pharma, LLC | $1,000.00 | 2025 | |
| Sumitomo Pharma America, INC. | $448.49 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $413.89 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $356.33 | 2021-2025 | |
| Olympus America INC. | $270.08 | 2024-2025 | Itind System |
| Calyxo, INC. | $261.31 | 2024-2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $257.10 | 2021-2023 | Nocdurna, Xyosted, Tlando |
| Tolmar, INC. | $242.86 | 2023-2025 | Eligard, Jatenzo |
| Blue Earth Diagnostics | $215.48 | 2020-2023 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Drevna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.